Insider · CIK 0001700283
Berger Mark Stanley
Reports to the SEC for 2 companies · AUSTIN, TX
Transactions
18
Companies
2
Filings
16
CIK
0001700283
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-02-27 | GNPXGenprex, Inc.F Tax Payment | −$14.3K |
| 2025-12-22 | GNPXGenprex, Inc.A Award | — |
| 2025-06-30 | GNPXGenprex, Inc.F Tax Payment | −$1,025.55 |
| 2025-02-18 | GNPXGenprex, Inc.F Tax Payment | −$239.85 |
| 2024-12-05 | GNPXGenprex, Inc.A Award | — |
| 2024-02-18 | GNPXGenprex, Inc.F Tax Payment | −$5,803.6 |
| 2023-02-18 | GNPXGenprex, Inc.A Award | — |
| 2022-02-04 | GNPXGenprex, Inc. · Stock Option (right to buy)A Award | — |
| 2021-09-27 | GNPXGenprex, Inc. · Stock Option (right to buy)A Award | — |
| 2021-09-01 | ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-08-12 | ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-07-12 | ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award | +$92.8K |
| 2019-03-05 | ATNMActinium Pharmaceuticals, Inc.X Exercise of In-Money | +$2,100 |
| 2018-07-13 | ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award | +$196K |
| 2018-03-06 | ATNMActinium Pharmaceuticals, Inc. · Series B WarrantsJ Other | +$5,250 |
| 2018-03-06 | ATNMActinium Pharmaceuticals, Inc. · Series A WarrantsJ Other | +$1,750 |
| 2018-03-06 | ATNMActinium Pharmaceuticals, Inc.J Other | +$7,000 |
| 2017-06-15 | ATNMActinium Pharmaceuticals, Inc.P Purchase | +$5,550 |
Recent filings
- 4Berger Mark Stanley0001437749-26-006154SEC(opens sec.gov)
- 4Berger Mark Stanley0001437749-25-038735SEC(opens sec.gov)
- 4Berger Mark Stanley0001437749-25-021819SEC(opens sec.gov)
- 4Berger Mark Stanley0001437749-25-004466SEC(opens sec.gov)
- 4Berger Mark Stanley0001437749-24-036878SEC(opens sec.gov)
- 4Berger Mark Stanley0001437749-24-005062SEC(opens sec.gov)
- 4Berger Mark Stanley0001437749-23-004241SEC(opens sec.gov)
- 4Berger Mark Stanley0001437749-22-002744SEC(opens sec.gov)
- 4Berger Mark Stanley0001437749-21-022776SEC(opens sec.gov)
- 4Berger Mark Stanley0001213900-21-046687SEC(opens sec.gov)
- 4Berger Mark Stanley0001213900-20-022337SEC(opens sec.gov)
- 4Berger Mark Stanley0001213900-19-012879SEC(opens sec.gov)
- 4Berger Mark Stanley0001213900-19-003738SEC(opens sec.gov)
- 4Berger Mark Stanley0001213900-18-009320SEC(opens sec.gov)
- 4Berger Mark Stanley0001213900-18-003155SEC(opens sec.gov)
- 4Actinium Pharmaceuticals, Inc.0001213900-17-006531SEC(opens sec.gov)
Companies
Address
3300 BEE CAVE ROAD #650-227
AUSTIN, TX, 78746